Crystallographic fragment screening

Methods in Molecular Biology

Volumn 841, Issue , 2012, Pages 161-177

  Badger, John ^a  

^a Zenobia Therapeutics   (United States)

Author keywords

Crystallography Software; Fragment library; Fragment screening; Synchrotron Radiation; X ray Crystallography

Indexed keywords

DRUG; PROTEIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CRYSTALLIZATION; DRUG DEVELOPMENT; METHODOLOGY; MOLECULAR LIBRARY; X RAY CRYSTALLOGRAPHY;

CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DRUG DISCOVERY; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; PROTEINS; SMALL MOLECULE LIBRARIES;

EID: 84856417177     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-520-6_7     Document Type: Article

References (15)

1. Hann, M.M., Leach, A.R. and Harper, G. (2001) Molecular complexity and its impact on the probability of finding leads for drug discovery J.Chem.Inf.Comput.Sci. 41 , 856-864.
2. Rees, D.C., Congreve, M., Murray, C.W. and Carr, R. (2004) Fragment-based lead discovery Nat. Rev. Drug Disc. 3 , 660-672. (Pubitemid 39173507)
3. Blundell, T.L., Jhoti, H. and Abell, C. (2002) High-throughput crystallography for lead discovery in drug design Nat. Rev. Drug Disc. 1 , 45-54. (Pubitemid 37361403)
4. Nienaber, V.L., Richardson, P.L., Klighofer, V., Bouska, J.J., Giranda, V.L. and Greer, J. (2000) Discovering novel ligands for macromolecules using X-ray crystallographic screening Nat. Biotechnol. 18 , 1105-1108.
5. Hajduk, P.J. and Greer, J. (2007) A decade of fragment-based drug design; strategic advances and lessons learned Nat. Rev. Drug Disc. 6 , 212-219.
6. Kuntz,I.D., Chen, K., Sharp, P.A. and Kollman, P.A. (1999) The maximal affinity of ligands Proc.Natl.Acad.Sci.U.S.A. 96 , 9997-10002. (Pubitemid 29422500)
7. Lipinski, C.A., Lombardo, B.W. Dominy and P.J. Feeney (1997) Experimental and omputational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Del. Rev. 23 , 3-25. (Pubitemid 27046991)
8. Pardridge, W.M. (2005) The Blood-brain Barrier: Bottleneck in Brain Drug Development The journal of the American Society for Experimental NeuroTherapeutics 2 , 3-14. (Pubitemid 40128022)
9. Bosch, J., Robien, M.A., Mehlin, C., Boni, E., Riechers, A., Buckner, F.S., Van Voorhis, W.C., Myler, P.J., Worthey, E.A., DeTitta, G., Luft, J.R., Lauricella, A., Gulde, S., Anderson, L.A., Kalyuzhniy, O., Neely, H.M., Ross, J., Earnest, T.N., Soltis, M., Schoenfeld, L., Zucker, F., Merritt, E.A., Fan, E., Verlinde, C.L.M.J. and Hol, W.G.J. (2006) Using Fragment Cocktail Crystallography To Assist Inhibitor Design of Trypanosoma brucei Nucleoside 2-Deoxyribosyltransferase J.Med Chem. 49 , 5939-5946. (Pubitemid 44484940)
10. Congreve, M., Carr, R., Murray, C. and Jhoti, H. (2003) A 'rule of three' for fragment-based lead discovery? Drug Discovery Today 8 , 876-877. (Pubitemid 37194496)
11. Hubbard, R.E., Davis, B., Chen, I. and Drysdale, M.J. (2007) The SeeDs Approach: Integrating Fragments into Drug Discovery Current Topics in Medicinal Chemistry 7 , 1-13.
12. Hartshorn, M.J., Murray, C.W., Cleasby, A., Frederickson, M., Tickle, I.J. and Jhoti, H. (2005) Fragment-Based Lead Discovery Using X-ray Crystallography JACS 48 , 403-413. (Pubitemid 40139783)
13. Collaborative Computational Project, Number 4 (1994) The CCP4 Suite: Programs for Protein Crystallography Acta Cryst. D50 , 760-763.
14. Brünger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros,P., Grosse-Kunstleve, R.W., Jiang, J.-S., Kuszewski, J., Nilges, M., Pannu, N.S., Read, R.J., Rice, L.M., Simonson, T. and Warren, G.L. (1998) Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination Acta Cryst. D 54 , 905-921.
15. Mooij, W.T.M., Hartshorn, M.J., Tickle, I.J., Sharff, A.J., Verdonk, M.L. and Jhoti, H. (2006) Automated Protein-Ligand Crystallography for Structure-Based Drug Design Chem. Med. Chem . 1 , 827-838. (Pubitemid 44384544)